{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:55:15Z","timestamp":1791060915960,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital","doi-asserted-by":"publisher","award":["2023-2025"],"award-info":[{"award-number":["2023-2025"]}],"id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital","doi-asserted-by":"publisher","award":["M1755"],"award-info":[{"award-number":["M1755"]}],"id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974377"],"award-info":[{"award-number":["81974377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2023JH2\/20200128"],"award-info":[{"award-number":["2023JH2\/20200128"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.trsl.2026.08.010","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:32:40Z","timestamp":1788305560000},"page":"98-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Micro-vascularized multicellular pancreatic ductal adenocarcinoma (PDAC) spheroid: A novel 3D PDAC research model"],"prefix":"10.1016","volume":"297","author":[{"given":"Hanrong","family":"LI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuhan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongli","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2378-1220","authenticated-orcid":false,"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.trsl.2026.08.010_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"9-10","key":"10.1016\/j.trsl.2026.08.010_bib0002","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1080\/0284186X.2016.1197419","article-title":"More deaths from pancreatic cancer than breast cancer in the EU by 2017","volume":"55","author":"Ferlay","year":"2016","journal-title":"Acta Oncol"},{"issue":"7","key":"10.1016\/j.trsl.2026.08.010_bib0003","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.010_bib0004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41571-019-0281-6","article-title":"From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer","volume":"17","author":"Nevala-Plagemann","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.010_bib0005","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.010_bib0006","first-page":"1309","article-title":"Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression","volume":"3","author":"Itakura","year":"1997","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.010_bib0007","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006676-200301000-00010","article-title":"Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer","volume":"26","author":"B\u00fcchler","year":"2003","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.010_bib0008","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.onc.1206122","article-title":"Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.010_bib0009","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9-10","key":"10.1016\/j.trsl.2026.08.010_bib0010","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.bjc.6690248","article-title":"Prognostic significance of angiogenesis in human pancreatic cancer","volume":"79","author":"Ikeda","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.trsl.2026.08.010_bib0011","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2014.10.015","article-title":"Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development","volume":"79-80","author":"Unger","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"issue":"22","key":"10.1016\/j.trsl.2026.08.010_bib0012","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.3390\/ijms222212200","article-title":"3D Cell culture systems: tumor application, advantages, and disadvantages","volume":"22","author":"Habanjar","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"48","key":"10.1016\/j.trsl.2026.08.010_bib0013","article-title":"Recapitulating pancreatic tumor microenvironment through synergistic use of patient organoids and organ-on-a-chip vasculature","volume":"30","author":"Lai Benjamin","year":"2020","journal-title":"Adv Funct Mater"},{"issue":"34","key":"10.1016\/j.trsl.2026.08.010_bib0014","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi9119","article-title":"Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment","volume":"7","author":"Neufeld","year":"2021","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.010_bib0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2012.04.045","article-title":"Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy","volume":"164","author":"Mehta","year":"2012","journal-title":"J Control Release"},{"issue":"34","key":"10.1016\/j.trsl.2026.08.010_bib0016","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1039\/C7PY00559H","article-title":"Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines","volume":"8","author":"Lazzari","year":"2017","journal-title":"Polym Chem"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.010_bib0017","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based drug screen: considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat Protoc"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.010_bib0018","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.3390\/molecules27092902","article-title":"Hydrogels: properties and applications in biomedicine","volume":"27","author":"Ho","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.010_bib0019","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/gels12050377","article-title":"GelMA versus agarose hydrogels in pancreatic cancer 3D spheroid modeling: effects on morphology, HIF-1\u03b1 expression, and gemcitabine response","volume":"12","author":"Celik","year":"2026","journal-title":"Gels"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.010_bib0020","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.3390\/ijms22052491","article-title":"Applications of biomaterials in 3D cell culture and contributions of 3D cell culture to drug development and basic biomedical research","volume":"22","author":"Park","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.010_bib0021","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.drudis.2017.01.012","article-title":"Designing a bio-inspired biomimetic in vitro system for the optimization of ex vivo studies of pancreatic cancer","volume":"22","author":"Totti","year":"2017","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.010_bib0022","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1038\/s41467-021-25921-9","article-title":"Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology","volume":"12","author":"Osuna de la Pe\u00f1a","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.010_bib0023","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1189\/jlb.70.5.793","article-title":"C1qR(P), a myeloid cell receptor in blood, is predominantly expressed on endothelial cells in human tissue","volume":"70","author":"Fonseca","year":"2001","journal-title":"J Leukoc Biol"},{"issue":"13","key":"10.1016\/j.trsl.2026.08.010_bib0024","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3390\/cells12131778","article-title":"Role of CD93 in health and disease","volume":"12","author":"Tossetta","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.010_bib0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbrc.2016.05.146","article-title":"Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma","volume":"476","author":"Bao","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2026.08.010_bib0026","article-title":"Pan-cancer analysis identified CD93 as a valuable biomarker for predicting patient prognosis and immunotherapy response","volume":"8","author":"Tong","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"12","key":"10.1016\/j.trsl.2026.08.010_bib0027","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.biomaterials.2011.01.057","article-title":"An overview of tissue and whole organ decellularization processes","volume":"32","author":"Crapo","year":"2011","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.010_bib0028","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1038\/ncomms4935","article-title":"Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink","volume":"5","author":"Pati","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.010_bib0029","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1741-7007-10-29","article-title":"Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation","volume":"10","author":"Vinci","year":"2012","journal-title":"BMC Biol"},{"issue":"7","key":"10.1016\/j.trsl.2026.08.010_bib0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"10","key":"10.1016\/j.trsl.2026.08.010_bib0031","doi-asserted-by":"crossref","first-page":"661","DOI":"10.5483\/BMBRep.2009.42.10.661","article-title":"Proteomic analysis of porcine pancreas development","volume":"42","author":"Choi","year":"2009","journal-title":"BMB Rep"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.010_bib0032","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.fsc.2023.05.005","article-title":"Degradation therapy with collagenase and deoxycholate","volume":"31","author":"McDonald","year":"2023","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.010_bib0033","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2015.11.047","article-title":"Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma","volume":"381","author":"Craven","year":"2016","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.010_bib0034","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.7150\/ijbs.67675","article-title":"Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression","volume":"18","author":"Chen","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"14","key":"10.1016\/j.trsl.2026.08.010_bib0035","doi-asserted-by":"crossref","first-page":"13611","DOI":"10.1021\/acsnano.3c02272","article-title":"Transforming cancer-associated fibroblast barrier into drug depots to boost chemo-immunotherapy in \"shooting fish in a barrel\" pattern","volume":"17","author":"Yuan","year":"2023","journal-title":"ACS Nano"},{"issue":"604","key":"10.1016\/j.trsl.2026.08.010_bib0036","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8922","article-title":"Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy","volume":"13","author":"Sun","year":"2021","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.010_bib0037","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/biom12020320","article-title":"Targeting the endocannabinoidome in pancreatic cancer","volume":"12","author":"Falasca","year":"2022","journal-title":"Biomolecules"},{"issue":"9414","key":"10.1016\/j.trsl.2026.08.010_bib0038","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","article-title":"Pancreatic cancer","volume":"363","author":"Li","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.010_bib0039","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrd1635","article-title":"What's wrong with our cancer models?","volume":"4","author":"Kamb","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.010_bib0040","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"48","key":"10.1016\/j.trsl.2026.08.010_bib0041","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202000545","article-title":"Recapitulating pancreatic tumor microenvironment through synergistic use of patient organoids and organ-on-a-chip vasculature","volume":"30","author":"Lai","year":"2020","journal-title":"Adv Funct Mater"},{"issue":"34","key":"10.1016\/j.trsl.2026.08.010_bib0042","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi9119","article-title":"Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment","volume":"7","author":"Neufeld","year":"2021","journal-title":"Sci Adv"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.010_bib0043","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based drug screen: considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat Protoc"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.010_bib0044","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc2544","article-title":"A tense situation: forcing tumour progression","volume":"9","author":"Butcher","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2026.08.010_bib0045","article-title":"The PDAC Extracellular matrix: A review of the ECM protein composition","volume":"11","author":"Perez","year":"2021","journal-title":"Tumor Cell Interact Ther Strateg Front Oncol"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.010_bib0046","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.3390\/ijms22052491","article-title":"Applications of biomaterials in 3D cell culture and contributions of 3D cell culture to drug development and basic biomedical research","volume":"22","author":"Park","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.trsl.2026.08.010_bib0047","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/ten.tec.2018.0180","article-title":"Evaluation of different decellularization protocols on the generation of pancreas-derived hydrogels","volume":"24","author":"Gaetani","year":"2018","journal-title":"Tissue Eng C: Methods"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.010_bib0048","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28857-1","article-title":"Extracellular matrix scaffold and hydrogel derived from decellularized and delipidized human pancreas","volume":"8","author":"Sackett","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2026.08.010_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.751311","article-title":"The PDAC Extracellular Matrix: a review of the ECM protein composition, tumor cell interaction, and therapeutic strategies","volume":"11","author":"Perez","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.010_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and cancer: a strained relationship","volume":"1873","author":"Piersma","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.010_bib0051","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0016-5085(98)70209-4","article-title":"Identification, culture, and characterization of pancreatic stellate cells in rats and humans","volume":"115","author":"Bachem","year":"1998","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.010_bib0052","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI66369","article-title":"Hepatic stellate cells in liver development, regeneration, and cancer","volume":"123","author":"Yin","year":"2013","journal-title":"J Clin Invest"},{"issue":"7162","key":"10.1016\/j.trsl.2026.08.010_bib0053","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.010_bib0054","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.trsl.2026.08.010_bib0055","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1158\/0008-5472.CAN-13-0530","article-title":"Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer","volume":"73","author":"Bochet","year":"2013","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.010_bib0056","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.010_bib0057","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.010_bib0058","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1158\/2159-8290.CD-15-0947","article-title":"GM-CSF mediates mesenchymal-epithelial cross-talk in pancreatic cancer","volume":"6","author":"Waghray","year":"2016","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.010_bib0059","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2019.05.012","article-title":"Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer","volume":"178","author":"Ligorio","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.010_bib0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/path.5224","article-title":"Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma","volume":"248","author":"Neuzillet","year":"2019","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.010_bib0061","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/MPA.0000000000000499","article-title":"Low stromal area and high stromal microvessel density predict poor prognosis in pancreatic cancer","volume":"45","author":"Nishida","year":"2016","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.010_bib0062","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.18632\/oncotarget.1887","article-title":"The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target","volume":"5","author":"Orlandini","year":"2014","journal-title":"Oncotarget"},{"issue":"44","key":"10.1016\/j.trsl.2026.08.010_bib0063","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1038\/onc.2017.214","article-title":"Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface","volume":"36","author":"Khan","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2026.08.010_bib0064","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.matbio.2017.08.003","article-title":"Dissecting the CD93-multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium","volume":"64","author":"Galvagni","year":"2017","journal-title":"Matrix Biol"},{"issue":"7","key":"10.1016\/j.trsl.2026.08.010_bib0065","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00384-015-2247-1","article-title":"CD93 gene polymorphism is associated with disseminated colorectal cancer","volume":"30","author":"Olsen","year":"2015","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.010_bib0066","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2796.2011.02364.x","article-title":"Plasma CD93 concentration is a potential novel biomarker for coronary artery disease","volume":"270","author":"M\u00e4larstig","year":"2011","journal-title":"J Intern Med"},{"issue":"11","key":"10.1016\/j.trsl.2026.08.010_bib0067","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.4049\/jimmunol.0902342","article-title":"CD93\/AA4.1: a novel regulator of inflammation in murine focal cerebral ischemia","volume":"184","author":"Harhausen","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.010_bib0068","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.1100803","article-title":"Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis","volume":"187","author":"Greenlee-Wacker","year":"2011","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.010_bib0069","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1172\/JCI97459","article-title":"CD93 promotes \u03b21 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis","volume":"128","author":"Lugano","year":"2018","journal-title":"J Clin Investig"},{"issue":"7","key":"10.1016\/j.trsl.2026.08.010_bib0070","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.169830","article-title":"CD93 maintains endothelial barrier function and limits metastatic dissemination","volume":"9","author":"Vemuri","year":"2024","journal-title":"JCI Insight"},{"issue":"22","key":"10.1016\/j.trsl.2026.08.010_bib0071","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212417","article-title":"CD93 Signaling via rho proteins drives cytoskeletal remodeling in spreading endothelial cells","volume":"22","author":"Barbera","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"604","key":"10.1016\/j.trsl.2026.08.010_bib0072","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8922","article-title":"Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy","volume":"13","author":"Sun","year":"2021","journal-title":"Sci Transl Med"},{"issue":"22","key":"10.1016\/j.trsl.2026.08.010_bib0073","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1200\/JCO.2010.28.1386","article-title":"Gemcitabine plus Bevacizumab compared with Gemcitabine Plus Placebo in patients with advanced pancreatic cancer: Phase III trial of the cancer and leukemia group B (CALGB 80303)","volume":"28","author":"Kindler","year":"2010","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.trsl.2026.08.010_bib0074","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1200\/JCO.2008.20.0238","article-title":"Phase III trial of Bevacizumab in combination with Gemcitabine and Erlotinib in patients with metastatic pancreatic cancer","volume":"27","author":"Van Cutsem","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:25:45Z","timestamp":1791059145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426001854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":74,"alternative-id":["S1931524426001854"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.08.010","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Micro-vascularized multicellular pancreatic ductal adenocarcinoma (PDAC) spheroid: A novel 3D PDAC research model","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}